ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,160Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 761

$824K Total Retail Price of All Prescriptions

Rank: 24 out of 761

617 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 617 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

18% of this provider’s 617 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 12,110 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
SIMVASTATIN 653 585 1 2
FUROSEMIDE 498 451 2 7
HYDROCODONE-ACETAMINOPHEN 468 368 S3 3 5
LISINOPRIL 454 386 4 1
LEVOTHYROXINE SODIUM 432 419 5 3
OMEPRAZOLE 410 387 6 4
AMLODIPINE BESYLATE 373 366 7 6
METFORMIN HCL 338 265 8 10
HYDROCHLOROTHIAZIDE 331 303 9 11
WARFARIN SODIUM 322 279 10 9
ATENOLOL 286 241 11 8
LOSARTAN POTASSIUM 284 284 12 13
LOVASTATIN 282 259 13 17
POTASSIUM CHLORIDE 267 260 14 18
GABAPENTIN 265 231 15 15
CITALOPRAM HBR 244 222 16 19
TRAZODONE HCL 196 167 17 23
ATORVASTATIN CALCIUM 176 169 18 12
CARVEDILOL 154 146 19 26
METOPROLOL SUCCINATE 151 143 20 16
METOPROLOL TARTRATE 143 137 21 14
ALLOPURINOL 142 127 22 28
FLUOXETINE HCL 137 80 23 31
PREDNISONE 136 125 24 30
ALENDRONATE SODIUM 129 129 25 21
OXYCODONE-ACETAMINOPHEN 124 110 S2 26 49
CRESTOR 116 98 27 36
ZOLPIDEM TARTRATE 113 92 28 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 109 91 29 35
PROAIR HFA 105 79 30 32
TRAMADOL HCL 102 86 31 34
CYMBALTA 100 72 32 53
TAMSULOSIN HCL 99 88 33 27
DONEPEZIL HCL 93 93 34 33
QUETIAPINE FUMARATE 90 88 35 90
METHADONE HCL 85 55 S2 36 75
PAROXETINE HCL 84 68 37 47
FLUTICASONE PROPIONATE 80 72 38 29
MIRTAZAPINE 78 70 39 50
DILTIAZEM 24HR CD 77 77 40 132
FENTANYL 74 38 S2 41 57
MELOXICAM 73 68 42 61
AMITRIPTYLINE HCL 73 61 R 42 54
OXYCODONE HCL 72 26 S2 44 24
LANTUS 71 64 45 41
CIPROFLOXACIN HCL 70 67 46 63
TRIAMTERENE-HCTZ 69 69 47 42
DILTIAZEM ER 69 66 47 130
FENOFIBRATE 69 59 47 91
DOXAZOSIN MESYLATE 62 62 50 55
ADVAIR DISKUS 62 54 50 37
GLYBURIDE 62 44 R 50 77
TRIAMCINOLONE ACETONIDE 61 55 53 84
PROPRANOLOL HCL 60 60 54 100
PRAVASTATIN SODIUM 59 59 55 20
QVAR 58 53 56 107
NIFEDIPINE ER 57 57 57 128
PANTOPRAZOLE SODIUM 56 35 58 40
LOSARTAN-HYDROCHLOROTHIAZIDE 56 53 58 65
TOPIRAMATE 53 42 60 186
NOVOLOG 53 45 60 129
SPIRIVA 52 50 62 56
CELEBREX 52 39 62 125
GLIMEPIRIDE 50 42 64 48
SUMATRIPTAN SUCCINATE 50 21 64 276
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 28, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.